XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents ($491 and $706 related to VIEs) $ 2,519 $ 2,439
Marketable securities ($0 and $130 related to VIEs) 69 185
Accounts receivable, net ($135 and $196 related to VIEs) 1,137 1,109
Contract assets ($171 and $186 related to VIEs) 991 915
Other current assets ($50 and $30 related to VIEs) 347 396
Total current assets 5,063 5,044
Noncurrent assets    
PP&E, net ($41 and $45 related to VIEs) 458 447
Investments 614 584
Deferred taxes 51 34
Deferred compensation trusts 241 234
Goodwill 206 206
Other assets ($127 and $54 related to VIEs) 340 278
Total noncurrent assets 1,910 1,783
Total assets 6,973 6,827
Current liabilities    
Accounts payable ($285 and $253 related to VIEs) 1,214 1,017
Short-term debt and current portion of long-term debt 0 152
Contract liabilities ($276 and $352 related to VIEs) 639 742
Accrued salaries, wages and benefits ($25 and $24 related to VIEs) 653 626
Other accrued liabilities ($73 and $46 related to VIEs) 657 679
Total current liabilities 3,163 3,216
Long-term debt 1,158 978
Deferred taxes 70 73
Other noncurrent liabilities ($20 and $54 related to VIEs) 530 564
Contingencies and commitments
Shareholders' equity    
Preferred stock — authorized 20,000,000 shares ($0.01 par value); issued and outstanding — 600,000 shares in 2022 0 0
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 170,405,512 and 142,322,247 shares in 2023 and 2022, respectively 2 1
APIC 1,228 1,254
AOCI (269) (365)
Retained earnings 979 896
Total shareholders' equity 1,940 1,786
NCI 112 210
Total equity 2,052 1,996
Total liabilities and equity $ 6,973 $ 6,827